Glass Pharms: initiating domestic supply of medical cannabis in the UK
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world’s first carbon-negative cannabis cultivation facility.
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world’s first carbon-negative cannabis cultivation facility.
Christopher Tasker of Global Cannabinoid Solutions (GCS) discusses the rise of delta-8-THC.
The new Common Agricultural Policy has been adopted in Europe that will allow a maximum THC level on the field of 0.3 per cent.
A new report has highlighted that the UK industry is struggling under ‘scientifically unjustified, and ethically unacceptable’ toxicity testing for CBD products.Â
Linneo Health has had its GMP certification renewed for its quality control laboratory and its post-harvest facility.
The NACA has signed three groundbreaking agreements which support the use of tribal farmland for cannabis cultivation.
Materia announced that its wholly-owned subsidiary, Materia Malta, has received the licence from the Malta Medicines Authority.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.